The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases
CCL2, a pivotal cytokine within the chemokine family, functions by binding to its receptor CCR2. The CCL2/CCR2 signaling pathway plays a crucial role in the development of fibrosis across multiple organ systems by modulating the recruitment and activation of immune cells, which in turn influences th...
Saved in:
Main Authors: | Shan Guo, Qi Zhang, Yingjie Guo, Xiaoyan Yin, Peng Zhang, Tao Mao, Zibin Tian, Xiaoyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1497026/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
by: Ya -Jing Li, et al.
Published: (2024-12-01) -
Bindarit attenuates neuroinflammation after subarachnoid hemorrhage by regulating the CCL2/CCR2/NF-κB pathway
by: Yanting Yao, et al.
Published: (2025-01-01) -
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
by: Raanan Greenman, et al.
Published: (2025-01-01) -
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis
by: Ryunosuke Nakagawa, et al.
Published: (2025-02-01) -
Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production
by: Brandon R. Scharpf, et al.
Published: (2025-01-01)